Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J McPartlin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 8, 2011
Non-standard radical treatment of skin cancerA J McPartlin, N J Slevin
The British Journal of Radiology|September 6, 2014
Radiotherapy treatment of non-melanoma skin cancer: a survey of current UK practice and commentaryA J McPartlin, N J Slevin, A J Sykes, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
Lung Cancer (Amsterdam, Netherlands)|May 7, 2013
The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderlyA J McPartlin, S Chaudhry, R Swindell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2016
MRI-guided prostate adaptive radiotherapy - A systematic reviewA J McPartlin, X A Li, L E Kershaw, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 8, 2011
Non-standard radical treatment of skin cancerA J McPartlin, N J Slevin
The British Journal of Radiology|September 6, 2014
Radiotherapy treatment of non-melanoma skin cancer: a survey of current UK practice and commentaryA J McPartlin, N J Slevin, A J Sykes, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
Lung Cancer (Amsterdam, Netherlands)|May 7, 2013
The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderlyA J McPartlin, S Chaudhry, R Swindell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2016
MRI-guided prostate adaptive radiotherapy - A systematic reviewA J McPartlin, X A Li, L E Kershaw, et al.
Pageof 1